What Are the Side Effects of Prolia, Fosamax and Reclast?

Older woman at a kitchen table reading the leaflet from a prescription box

What Are the Side Effects of Prolia, Fosamax and Reclast?

For most people the side effects are mild, and the feared ones are rare. Fosamax can irritate the esophagus, Reclast often causes a day or two of flu-like aches, and Prolia’s biggest risk comes from stopping it without a follow-on drug. Jaw bone death and unusual thigh-bone fractures affect about 1 in 10,000 people or fewer at osteoporosis doses.

The answers below come from the main drug trials, reviews and large follow-up studies. I give the fracture benefit as absolute risk too, so you can weigh it against the harm.

What the Data Show

“NNT” is the number needed to treat: how many people take the drug for one to avoid a fracture.

Drug (generic)How it is givenSpine fractures, drug vs comparisonMain side effects
Prolia (denosumab)Shot every 6 months2.3% vs 7.2% placebo over 3 years (NNT about 20)Similar to placebo; low calcium in kidney failure; rebound fractures if stopped
Fosamax (alendronate)Weekly pill2.7 points fewer clinical spine fractures in women with osteoporosis (NNT about 37)Stomach side effects about the same as placebo in trials
Reclast (zoledronic acid)Yearly infusion3.3% vs 10.9% placebo over 3 years (NNT about 13)Flu-like aches after the first dose; atrial fibrillation
Evenity (romosozumab)Monthly shots for 12 months6.2% vs 11.9% on Fosamax (NNT about 18)Slightly more heart attacks and strokes
Forteo (teriparatide)Daily shot5% vs 14% placebo (NNT about 11)Occasional nausea and headache

These come from different trials in different women, so they are not a direct ranking.

What Are the Side Effects of Prolia?

In the FREEDOM trial of 7,868 women aged 60 to 90, Prolia every 6 months for 3 years caused no increase in cancer, infection, heart disease, slow fracture healing or low calcium, and no cases of jaw osteonecrosis. Spine fractures fell from 7.2% to 2.3%, about 1 in 20 women helped. Hip fractures fell from 1.2% to 0.7%, about 1 in 200.

The serious exception is kidney failure. Prolia lowers blood calcium, and healthy kidneys make up for it. In a study of 2,804 women aged 65 and older on dialysis, 41.1% developed severely low calcium within 12 weeks of starting Prolia, compared with 2.0% on oral bisphosphonates. Very low calcium can cause cramps, tingling and heart rhythm problems.

Jubbonti is a biosimilar of Prolia, a near-copy of the same antibody, so the same cautions apply to it.

What Happens When You Stop Prolia?

This is the side effect that matters most. Prolia holds back the cells that break down bone, and when a dose is missed, those cells come back in force. In a follow-up of 1,001 women who stopped Prolia, bone breakdown markers rose above baseline by 6 months, and bone density fell back to where it started within 12 months.

Spine fractures rose from 1.2 per 100 women per year on treatment to 7.1 after stopping, close to the 8.5 seen after stopping placebo. Of the women who broke a spine bone after stopping Prolia, 60.7% broke more than one, compared with 38.7% after placebo. The authors concluded that people who stop Prolia should move quickly to another drug that slows bone breakdown.

So Prolia is not a drug to let lapse by a few months. The exit plan belongs in the conversation before the last dose.

What Are the Side Effects of Fosamax (Alendronate)?

Fosamax belongs to a drug family called bisphosphonates, along with Actonel (risedronate), Boniva (ibandronate) and Reclast. The pill’s best-known problem is irritation of the esophagus, the tube from the throat to the stomach, which can cause heartburn or pain on swallowing.

In trials, that problem was less common than its reputation. A Cochrane review of 119 alendronate studies found little or no difference in stomach side effects between alendronate and placebo, and no cases of jaw osteonecrosis or atypical femur fracture. In women who already had osteoporosis or a spine fracture, alendronate cut clinical spine fractures by 2.7 percentage points (about 1 in 37 helped) and hip fractures by 1.0 point (1 in 100).

Some people do feel unwell on it. Severe bone, joint or muscle pain is a listed side effect of bisphosphonates. Taking the pill the right way prevents most esophagus trouble: swallow it first thing in the morning with a full glass of plain water, then stay upright for at least 30 minutes. Wait those 30 minutes before food, coffee, juice, milk, calcium or other pills, because they block absorption.

Can You Take a Break From Fosamax?

Yes, for many people, because bisphosphonates stay stored in bone. In the FLEX trial of 1,099 women who had taken alendronate for about 5 years, those switched to placebo for 5 more years lost some bone density, but it stayed at or above their starting level. Nonvertebral fractures were the same in both groups, 18.9% and 19%. Clinical spine fractures were higher after stopping, 5.3% compared with 2.4%, so women at very high risk may do better staying on it.

What Are the Side Effects of a Reclast Infusion?

The most common is an acute phase reaction: fever, aches, fatigue and joint pain in the days after the drip, a lot like the flu. In a study of 1,150 patients given zoledronic acid, 75% reported at least one symptom and 22% rated a symptom as severe. Symptoms were tied most to the first infusion, younger age and no earlier bisphosphonate use. Taking a pain reliever ahead of time was linked to fewer aches, and 94% said they would have it again.

In the HORIZON trial of 7,765 women, side effects overall, including kidney changes, were similar to placebo. Serious atrial fibrillation, an irregular heart rhythm, occurred in 50 women on the drug compared with 20 on placebo, out of about 3,900 in each group. One infusion a year for 3 years cut spine fractures from 10.9% to 3.3%, about 1 in 13 women helped, and hip fractures from 2.5% to 1.4%, about 1 in 91.

What Are the Side Effects of Evenity, and Is It Better Than Prolia?

Evenity builds new bone instead of only slowing bone loss. It is given as monthly shots for 12 months. In the ARCH trial of 4,093 women who had already broken a bone, a year of Evenity followed by alendronate cut new spine fractures to 6.2%, compared with 11.9% on alendronate alone. Hip fractures were 2.0% compared with 3.2%.

The concern is the heart. In the first year, serious heart and blood vessel events, such as heart attack and stroke, occurred in 2.5% of women on Evenity and 1.9% on alendronate: about 1 extra event for every 167 women. The trial was funded by Amgen, which makes Evenity.

No large trial has compared Evenity with Prolia head to head for fractures.

What Are the Side Effects of Forteo?

Forteo is a daily shot of a piece of parathyroid hormone that builds bone. In a trial of 1,637 women with earlier spine fractures, the approved 20 microgram dose cut new spine fractures from 14% to 5%, about 1 in 11 women helped. The researchers reported only minor side effects, mainly occasional nausea and headache.

How Common Is Jaw Osteonecrosis From Bone Drugs?

Osteonecrosis of the jaw means a patch of jawbone loses its blood supply and is exposed in the mouth. An international task force review estimated it at 0.001% to 0.01% in people taking these drugs for osteoporosis, only a little above the rate in the general population. In cancer patients, who get much higher doses more often, the rate is 1% to 15%. Most frightening stories come from that group. The task force listed added risk factors, including steroid use, jaw surgery, poor oral hygiene, diabetes and poorly fitting dentures.

How Common Are Atypical Femur Fractures?

An atypical femur fracture is an unusual break straight across the thigh bone, often with little or no injury. A study of 196,129 women on bisphosphonates found 277 of them. Risk climbed with years of use, was higher in Asian women than White women, and dropped quickly after stopping. After 3 years of use, 149 hip fractures were prevented for every 2 atypical fractures in White women, and 91 for every 8 in Asian women.

What Is the Best and Safest Osteoporosis Treatment?

There is no single best drug. It depends on your fracture risk, kidneys, heart, and whether you can take a pill correctly. A network meta-analysis of 107 trials in 193,987 women found the largest drops in fracture risk with teriparatide (Forteo), abaloparatide, denosumab (Prolia) and romosozumab (Evenity). Ibandronate (Boniva) had lower efficacy.

Dr. Kumar’s Take

The fear around these drugs is out of proportion to the numbers. Jaw osteonecrosis and atypical thigh fractures are real, but at osteoporosis doses they are counted in single cases per 10,000 people. A hip fracture in an older adult is common and often ends independent living. For someone who has already broken a bone, these trials show far more fractures prevented than caused.

The risk that gets too little attention is Prolia’s off-switch. It works well while you take it, but a lapse of a few months can bring several spine fractures at once. Anyone starting it should know that it needs an exit plan.

Practical Takeaways

  • Take Fosamax correctly: plain water, upright and nothing else by mouth for 30 minutes.
  • Expect flu-like aches after a first Reclast infusion.
  • Never let Prolia lapse. Keep the 6-month schedule and plan the next drug before stopping.
  • Get dental work done before starting and keep up with cleanings.
  • Report new thigh or groin pain while on a bisphosphonate or Prolia.

FAQs

How long after a Prolia injection do side effects start?

In dialysis patients, severe low calcium developed within the first 12 weeks. After a missed dose, bone breakdown starts rising about 3 months later.

What are the 3 worst bone density drugs?

No drug is worst for everyone. Prolia carries the biggest risk if stopped without a plan, Evenity a small added heart risk, and Boniva the weakest record for preventing fractures.

Is Reclast safer than Fosamax?

They are the same drug family with similar rare risks. Reclast skips the esophagus irritation of the pill but often causes flu-like aches after the first infusion, and it was linked to more serious atrial fibrillation in its main trial.

Does stopping Fosamax cause rebound fractures like Prolia?

No. Alendronate stays stored in bone, and in a 5-year trial of stopping, most fracture rates did not rise. Only clinical spine fractures were higher.

Bottom Line

The common side effects of osteoporosis drugs are mostly mild: heartburn from Fosamax, a few days of aches after Reclast, nausea with Forteo. Jaw osteonecrosis and atypical thigh fractures are rare, and in high-risk women each drug prevents far more fractures than it causes. The risks that deserve attention are stopping Prolia without a follow-on drug, low calcium with Prolia in kidney failure, and the small heart risk with Evenity.

References

  1. Cummings SR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis (FREEDOM). N Engl J Med, 2009 pubmed.ncbi.nlm.nih.gov
  2. Cummings SR, et al. Vertebral fractures after discontinuation of denosumab: post hoc analysis of FREEDOM and its extension. J Bone Miner Res, 2018 pubmed.ncbi.nlm.nih.gov
  3. Bird ST, et al. Severe hypocalcemia with denosumab among older female dialysis-dependent patients. JAMA, 2024 pubmed.ncbi.nlm.nih.gov
  4. Wells GA, et al. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev, 2025 pubmed.ncbi.nlm.nih.gov
  5. Black DM, et al. Effects of continuing or stopping alendronate after 5 years of treatment (FLEX). JAMA, 2006 pubmed.ncbi.nlm.nih.gov
  6. Black DM, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis (HORIZON). N Engl J Med, 2007 pubmed.ncbi.nlm.nih.gov
  7. Longobardi V, et al. Acute-phase reactions to zoledronate in clinical practice: a prospective study of 1,150 patients. Endocrine, 2026 pubmed.ncbi.nlm.nih.gov
  8. Saag KG, et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis (ARCH). N Engl J Med, 2017 pubmed.ncbi.nlm.nih.gov
  9. Neer RM, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med, 2001 pubmed.ncbi.nlm.nih.gov
  10. Khan AA, et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res, 2015 pubmed.ncbi.nlm.nih.gov
  11. Black DM, et al. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med, 2020 pubmed.ncbi.nlm.nih.gov
  12. Barrionuevo P, et al. Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis. J Clin Endocrinol Metab, 2019 pubmed.ncbi.nlm.nih.gov

Get Dr. Kumar's free health protocols

Evidence-based playbooks from Dr. Ravi Kumar, MD, a board-certified neurosurgeon, plus a weekly research review. Enter your email and I'll send you the relevant protocol.

By subscribing, you agree to receive emails from The Dr Kumar Discovery. You can unsubscribe at any time. Privacy Policy

The Dr Kumar Discovery Podcast
Podcast

The Dr Kumar Discovery

Where science meets common sense. Practical, unbiased answers to today's biggest health questions.

Browse all episodes →